These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7426281)

  • 1. Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.
    Faed EM
    Br J Clin Pharmacol; 1980 Aug; 10(2):185-6. PubMed ID: 7426281
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.
    Levy G
    Br J Clin Pharmacol; 1979 Dec; 8(6):601. PubMed ID: 533584
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of alkaline diuresis to enhance diflunisal elimination.
    Balali-Mood M; Prescott LF
    Br J Clin Pharmacol; 1980 Aug; 10(2):163-5. PubMed ID: 7426277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary excretion of diflunisal conjugates in patients with T-tube drainage.
    Verbeeck RK; Dickinson RG; Pond SM
    Eur J Clin Pharmacol; 1988; 34(4):423-6. PubMed ID: 3402529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.
    Loewen GR; Herman RJ; Ross SG; Verbeeck RK
    Br J Clin Pharmacol; 1988 Jul; 26(1):31-9. PubMed ID: 3203058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both phenolic and acyl glucuronidation pathways of diflunisal are impaired in liver cirrhosis.
    Macdonald JI; Wallace SM; Mahachai V; Verbeeck RK
    Eur J Clin Pharmacol; 1992; 42(5):471-4. PubMed ID: 1606992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diflunisal disposition and hypouricemic response in osteoarthritis.
    Meffin PJ; Brooks PM; Bertouch J; Veenendaal JR; Harrington BJ
    Clin Pharmacol Ther; 1983 Jun; 33(6):813-21. PubMed ID: 6851413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review.
    Verbeeck RK
    Drug Metab Dispos; 1982; 10(1):87-9. PubMed ID: 6124391
    [No Abstract]   [Full Text] [Related]  

  • 9. Diflunisal and its conjugates in patients with renal failure.
    Dickinson RG; Verbeeck RK; King AR; Restifo AC; Pond SM
    Br J Clin Pharmacol; 1991 May; 31(5):546-50. PubMed ID: 1888623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.
    Verbeeck R; Tjandramaga TB; Mullie A; Verbesselt R; Verberckmoes R; de Schepper PJ
    Br J Clin Pharmacol; 1979 Mar; 7(3):273-82. PubMed ID: 427004
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure.
    Lin JH; Ulm EH; Duggan DE
    J Pharmacol Exp Ther; 1986 Sep; 238(3):978-84. PubMed ID: 3746671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states.
    Tobert JA; DeSchepper P; Tjandramaga TB; Mullie A; Buntinx AP; Meisinger MA; Huber PB; Hall TL; Yeh KC
    Clin Pharmacol Ther; 1981 Sep; 30(3):385-9. PubMed ID: 7023791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
    Verbeeck RK; De Schepper PJ
    Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in rats.
    Lin JH; Chen IW; Ulm EH; Duggan DE
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1013-8. PubMed ID: 3656106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats.
    Lin JH; Yeh KC; Duggan DE
    Drug Metab Dispos; 1985; 13(3):321-6. PubMed ID: 2861991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of multiple dosage on the kinetics of glucuronidation and sulphation of diflunisal in man.
    Verbeeck RK; Loewen GR; MacDonald JI; Herman RJ
    Br J Clin Pharmacol; 1990 Apr; 29(4):381-9. PubMed ID: 2328191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of diethyl ether, pentobarbitone and urethane anaesthesia on diflunisal conjugation and disposition in rats.
    Watt JA; Dickinson RG
    Xenobiotica; 1990 Mar; 20(3):289-301. PubMed ID: 2336839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-dose kinetics and dialyzability of oxazepam in renal insufficiency.
    Greenblatt DJ; Murray TG; Audet PR; Locniskar A; Koepke HH; Walker BR
    Nephron; 1983; 34(4):234-8. PubMed ID: 6877459
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolism.
    Lin JH; Hooke KF; Yeh KC; Duggan DE
    J Pharmacol Exp Ther; 1985 Nov; 235(2):402-6. PubMed ID: 4057077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucuronidation and elimination of diflunisal in the isolated perfused rat liver: effect of pretreatment with phenobarbitone, clofibric acid and spironolactone.
    Faed EM; Dobbs BR; Lee D
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):4-16. PubMed ID: 6517647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.